Indirect Purchasers Certified In Wellbutrin Antitrust Suit
A Pennsylvania federal judge on Monday granted class certification to a group of indirect purchasers of Wellbutrin XL and its generic equivalent in a suit that accuses drugmakers Biovail Corp. and GlaxoSmithKline PLC...To view the full article, register now.
Already a subscriber? Click here to view full article